Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes C M van der Loo

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Human Molecular Genetics|November 1, 2015
Progress and challenges in viral vector manufacturingJohannes C M van der Loo, J Fraser Wright
Journal of Visualized Experiments : Jove|April 24, 2018
Production and Purification of Baculovirus for Gene Therapy ApplicationMd Nasimuzzaman, Johannes C M van der Loo, Punam Malik
Methods in Molecular Biology (Clifton, N.J.)|December 27, 2008
Design and production of retro- and lentiviral vectors for gene expression in hematopoietic cellsAxel Schambach, William P Swaney, Johannes C M van der Loo
Journal of Visualized Experiments : Jove|January 31, 2022
Process Development for the Production and Purification of Adeno-Associated Virus (AAV)2 Vector using Baculovirus-Insect Cell Culture SystemMd Nasimuzzaman, Sophia Villaveces, Johannes C M van der Loo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2007
PU.1 redirects adenovirus to lysosomes in alveolar macrophages, uncoupling internalization from infectionBrenna Carey, Margaret K Staudt, Dana Bonaminio, et al.
Human Gene Therapy|August 7, 2002
Optimization of gene transfer into primitive human hematopoietic cells of granulocyte-colony stimulating factor-mobilized peripheral blood using low-dose cytokines and comparison of a gibbon ape leukemia virus versus an RD114-pseudotyped retroviral vectorJohannes C M van der Loo, B L Liu, A I Goldman, et al.
Experimental Hematology|September 10, 2003
Homing defect of cultured human hematopoietic cells in the NOD/SCID mouse is mediated by Fas/CD95Bianling Liu, Sharron M Buckley, Ian D Lewis, et al.
Molecular Therapy. Methods & Clinical Development|August 22, 2024
Evaluation of a rapid multi-attribute combinatorial high-throughput UV-Vis/DLS/SLS analytical platform for rAAV quantification and characterizationXueyuan Liu, Riffard Jean-Gilles, Julia Baginski, et al.
Cell Transplantation|May 20, 2021
Selecting a Cell Engineering Methodology During Cell Therapy Product DevelopmentLauren M Timmins, Alexandra M Burr, Kristina Carroll, et al.
Human Gene Therapy. Clinical Development|November 14, 2017
The Gene Therapy Resource Program: A Decade of Dedication to Translational Research by the National Heart, Lung, and Blood InstituteTerence R Flotte, Eric Daniels, Janet Benson, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Human Molecular Genetics|November 1, 2015
Progress and challenges in viral vector manufacturingJohannes C M van der Loo, J Fraser Wright
Journal of Visualized Experiments : Jove|April 24, 2018
Production and Purification of Baculovirus for Gene Therapy ApplicationMd Nasimuzzaman, Johannes C M van der Loo, Punam Malik
Methods in Molecular Biology (Clifton, N.J.)|December 27, 2008
Design and production of retro- and lentiviral vectors for gene expression in hematopoietic cellsAxel Schambach, William P Swaney, Johannes C M van der Loo
Journal of Visualized Experiments : Jove|January 31, 2022
Process Development for the Production and Purification of Adeno-Associated Virus (AAV)2 Vector using Baculovirus-Insect Cell Culture SystemMd Nasimuzzaman, Sophia Villaveces, Johannes C M van der Loo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2007
PU.1 redirects adenovirus to lysosomes in alveolar macrophages, uncoupling internalization from infectionBrenna Carey, Margaret K Staudt, Dana Bonaminio, et al.
Human Gene Therapy|August 7, 2002
Optimization of gene transfer into primitive human hematopoietic cells of granulocyte-colony stimulating factor-mobilized peripheral blood using low-dose cytokines and comparison of a gibbon ape leukemia virus versus an RD114-pseudotyped retroviral vectorJohannes C M van der Loo, B L Liu, A I Goldman, et al.
Experimental Hematology|September 10, 2003
Homing defect of cultured human hematopoietic cells in the NOD/SCID mouse is mediated by Fas/CD95Bianling Liu, Sharron M Buckley, Ian D Lewis, et al.
Molecular Therapy. Methods & Clinical Development|August 22, 2024
Evaluation of a rapid multi-attribute combinatorial high-throughput UV-Vis/DLS/SLS analytical platform for rAAV quantification and characterizationXueyuan Liu, Riffard Jean-Gilles, Julia Baginski, et al.
Cell Transplantation|May 20, 2021
Selecting a Cell Engineering Methodology During Cell Therapy Product DevelopmentLauren M Timmins, Alexandra M Burr, Kristina Carroll, et al.
Human Gene Therapy. Clinical Development|November 14, 2017
The Gene Therapy Resource Program: A Decade of Dedication to Translational Research by the National Heart, Lung, and Blood InstituteTerence R Flotte, Eric Daniels, Janet Benson, et al.
Pageof 2